大象tv

American Cancer Society. Cancer Facts and Figures, 2016. Atlanta, Ga: American Cancer Society; 2016.

American Cancer Society. Cancer Facts and Figures, 2017. Atlanta, Ga: American Cancer Society; 2017.

American Joint Committee on Cancer. Bone. AJCC Cancer Staging Manual. 7^th ed. New York:.Springer-Verlag; 2010: 281-287.

Bjornsson J, McLeod RA, Unni KK, et al. Primary chondrosarcoma of long bones and limb girdles. Cancer. 1998;83:1945-2008.

Bovee JV, Cleton-Jansen A, Taminiau AH, Hogendoom PCW. Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment. Lancet Oncology. 2005;6:599-607.

Casali PG, Stacchiotti S, Grosso F, et al. Adding cisplatin (CDDP) to imatinib (IM) reestablishes tumor response following secondary resistance to IM in advanced chordoma. 2007 ASCO Annual Meeting Proceedings Part 1. J Clin Oncol. 2007;25 (18S): Abstract #10038.

Casali PG, Messina A, Stacchiotti S, et al. Imatinib mesylate in chordoma. Cancer. 2004;101(9):2086-2097.

Chawla S, Henshaw R, Seeger L, et al. Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study. Lancet Oncol. 2013;14(9):901-908. Epub 2013 Jul 16.

Damron TA, Ward WG, Stewart A. Osteosarcoma, chondrosarcoma, and Ewing鈥檚 sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res. 2007;459:40-47.

Engels EA, Fraumeni Jr JF. New Malignancies Following Cancer of the Bone and Soft Tissue, and Kaposi Sarcoma. In: Curtis RE, Freedman DM, Ron E, Ries LAG, Hacker DG, Edwards BK, Tucker MA, Fraumeni JF Jr. (eds). New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. National Cancer Institute. NIH Publ. No. 05-5302. Bethesda, MD, 2006. Accessed on 4/18/2014 at http://seer.cancer.gov/archive/publications/mpmono/MPMonograph_complete.pdf.

Gebhardt MC, Springfield D, Neff JR. Sarcomas of bone. In: Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE. Kastan MB, McKenna WG, eds. Clinical Oncology. 4^th ed. Philadelphia, Pa.: Elsevier; 2008: 2471-2572.

Gelderblom H, Hogendoorn PC, Dijkstra SD, et al. The clinical approach towards chondrosarcoma. Oncologist. 2008;13:320-329.

Giuffrida AY, Burgueno JE, Koniaris LG, et al. Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database. J Bone Joint Surg Am. 2009;91(5):1063-1072.

Hansen MF, Seton M, Merchant A. Osteosarcoma in Paget鈥檚 disease of bone. J Bone Miner Res. 2006;21 Suppl 2:P58-63.

Lewis DR, Ries LAG. Cancers of the bone and joint. In, Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner M-J (editors). SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Cancer Institute, SEER Program, NIH Pub. No. 07-6215, Bethesda, MD, 2007.

Malawer MM, Helman LJ, O鈥橲ullivan B. Sarcomas of bone. In: DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology. 9^th ed. Philadelphia, Pa.: Lippincott Williams & Wilkins; 2011: 1578-1609.

National Comprehensive Cancer Network (NCCN). Practice Guidelines in Oncology: Bone Cancer. Version 1,2014. Accessed at www.nccn.org on January 6, 2014.

Online Mendelian Inheritance in Man, OMIM (TM). McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University (Baltimore, MD) and National Center for Biotechnology Information, National Library of Medicine (Bethesda, MD). Accessed at http://omim.org/ on October 11, 2012.

Springfield D, Rosen G. Bone tumors. In: Kufe DW, Bast RC, Hait WN, Hong WK, Pollock RE, Weichselbaum RR, Holland JF, Frei E, eds. Cancer Medicine, 7^th ed. Hamilton, Ontario: BC Decker; 2006: 1675-1693.

Stacchiotti S, Marrari A, Tamborini E, et al. Response to imatinib plus sirolimus in advanced chordoma. Ann Oncol. 2009;20(11):1886-1894.

Stacchiotti S, Longhi A, Ferraresi V, et al. Phase II study of imatinib in advanced chordoma. J Clin Oncol. 2012;30(9):914-920. Epub 2012 Feb 13.

Stacchiotti S, Tamborini E, Lo Vullo S, et al. Phase II study on lapatinib in advanced EGFR-positive chordoma. Ann Oncol. 2013;24(7):1931-1936. Epub 2013 Apr 4.

Tarpey PS, Behjati S, Cooke SL, et al. Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat Genet. 2013;45(8):923-926. Epub 2013 Jun 16.

Thomas DM, Skubitz KM. Giant cell tumour of bone. Curr Opin Oncol. 2009;21(4):338-344.

Thomas D, Henshaw R, Skubitz K, et al. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol. 2010;11(3):275-280.

Walcott BP, Nahed BV, Mohyeldin A, et al. Cordoma: current concepts, management, and future directions. Lancet Oncol. 2012;13(2):e69-76.